The UCLA Lymphoma Program is exclusively dedicated to diagnosis, treatment and management of patients with lymphomas. Our multidisciplinary team is dedicated to getting you through your fight with cancer. We have a world-renowned research program designed to translate the latest discoveries into clinical applications for patients.
Why choose the UCLA Lymphoma Program?
A part of the UCLA Division of Hematology-Oncology (at the David Geffen School of Medicine), the Lymphoma Program provides one-on-one care for patients by an oncologist who specializes exclusively in the management and treatment of lymphomas. While our doctors have a broad background in hematology, oncology, internal medicine and hematopathology, they have distinctive expertise and experience in management of lymphomas. Everyone involved in program is specifically trained to care for lymphomas, and our facilities and resources are dedicated to the care of lymphoma patients.
Our team at the UCLA Lymphoma Program rallies around you, delivering personalized, compassionate care. Patients are cared for personally by their doctors. We are committed to providing patients the information and resources needed to make informed decisions about their treatment. We honor their strength and courage, and we encourage and empower them to be part of the recovery process. Our integrated team is committed to caring for and treating all of you, not just your disease. Through our integrated, comprehensive program, all our patients have access to a full range of services, including education, wellness, nutritional guidance, psychological support and survivorship resources.
Our team includes medical oncologists specializing exclusively in the treatment of patients with lymphoma, radiation oncologists, pathologists, radiologists and lymphoma imaging specialists, as well as specialists in nutrition, psychological and emotional well-being and support, social workers, financial counselors, and patient advocates.
Clinical trials are carefully controlled research studies in which cancer patients help doctors and scientists find ways to improve health and cancer care, and to make sure the treatments are safe and effective. Each study is designed to address and answer specific scientific questions and to find better ways to prevent, diagnose or treat cancer. A clinical trial is one of the final stages resulting from the research conducted during intensive and lengthy laboratory studies.
Patients in the UCLA Lymphoma Program have access to the latest and most advanced treatments available for lymphomas. We have a national reputation for developing new cancer therapies and providing the best in both experimental and traditional treatments. Our research program is designed to translate the latest laboratory discoveries into clinical applications for our patients. We also have an active clinical trials program, providing patients access to the most advanced treatment options. Some of the most successful targeted therapies for cancer and blood diseases, such as Gleevec and Sprycel, were developed based on basic science research performed in UCLA laboratories, and through clinical trials with UCLA patients.
If you are interested in finding out more about these studies, visit our Clinical Trials Guide for general information and a listing of currently open clinical trials.
For more information on lymphomia treatment services at UCLA, visit the following related websites: